Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Ahmad, Adeli"'
Autor:
Masoume Bazaz, Ahmad Adeli, Mohammad Azizi, Morteza Karimipoor, Freidoun Mahboudi, Noushin Davoudi
Publikováno v:
AMB Express, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract The demand for industrial genetically modified host cells were increased with the growth of the biopharmaceutical market. Numerous studies on improving host cell productivity have shown that altering host cell growth and viability through ge
Externí odkaz:
https://doaj.org/article/2255bd44ad744e089da2f043e4ffa9ae
Autor:
Akbar Oghalaei, Feriedon Mahbudi, Fatemeh Rahimi Jamnani, Somayeh Piri-Gavgani, Fatemeh Kazemi-Lomedasht, Aida Hassanzadeh-Eskafi, Delavar Shahbazzadeh, Ahmad Adeli, Yeganeh Talebkhan, Mahdi Behdani
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 25, Iss 3, Pp 313-319 (2022)
Objective(s): One of the important interactions in controlling the human immune system is the reaction between checkpoint proteins such as programmed cell death-1 (PD-1) and its ligand, PD-L1. These are negative immunoregulatory molecules that promot
Externí odkaz:
https://doaj.org/article/bef2315b61c24a02aaeefcfffe6ae95c
Publikováno v:
APMIS.
Autor:
Shadi Damough, Reyhaneh Alizadeh, Samira Komijani, Mahsa Shirin, Ahmad Adeli, Ladan Mafakher, Fereidoun Mahboudi, Yeganeh Talebkhan Garoosi
Publikováno v:
Iranian Journal of Pharmaceutical Research. 21
Background: Overexpression of CD20 protein on the surface of B cells in lymphoma can be targeted by several anti-CD20 molecules. The development of accessible interactive epitopes is more favorable than the full-length transmembrane CD20 in the affin
Autor:
Akbar, Oghalaie, Fereidoun, Mahboudi, Fatemeh, Rahimi-Jamnani, Somayeh, Piri-Gavgani, Fatemeh, Kazemi-Lomedasht, Ayda, Hassanzadeh Eskafi, Delavar, Shahbazzadeh, Ahmad, Adeli, Yeganeh, Talebkhan, Mahdi, Behdani
Publikováno v:
Iranian journal of basic medical sciences. 25(3)
One of the important interactions in controlling the human immune system is the reaction between checkpoint proteins such as programmed cell death-1 (PD-1) and its ligand, PD-L1. These are negative immunoregulatory molecules that promote immune evasi
Autor:
Masoume Bazaz, Ahmad Adeli, Mohammad Azizi, Masoud Soleimani, Fereidoun Mahboudi, Noushin Davoudi
Publikováno v:
Biotechnology letters. 44(5-6)
It is widely accepted that the growing demand for recombinant therapeutic proteins has led to the expansion of the biopharmaceutical industry and the development of strategies to increase recombinant protein production in mammalian cell lines such as
Autor:
Elham Bayat, Farzaneh Barkhordari, Ahmad Adeli, Hoda Jahandar, Fereidoun Mahboudi, Shadi Damough, Yeganeh Talebkhan, Leila Nematollahi, Fatemeh Torkashvand, Masoumeh Sabzalinezhad
Publikováno v:
Protein Expression and Purification
Protein Expression and Purification, Elsevier, 2021, 179, pp.105805-. ⟨10.1016/j.pep.2020.105805⟩
Protein Expression and Purification, Elsevier, 2021, 179, pp.105805-. ⟨10.1016/j.pep.2020.105805⟩
Anti-TNF inhibitors exert their therapeutic effect by inhibition of the excessive amounts of TNF-α within the body. Recombinant TNF-α should be produced in a soluble refolded form to investigate the effectiveness and efficiency of anti-TNF-α compo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9ad17b1dd4d08b699faf64926ecdaa9
https://hal.archives-ouvertes.fr/hal-03493334
https://hal.archives-ouvertes.fr/hal-03493334
Autor:
Azam Bolhassani, Marzieh Ghahremanlou, Ahmad Adeli, Mohammad Azizi, Taraneh Rajaee, Noushin Davoudi, Nikky Tofighi, Mohammad Mehdi Attarpour Yazdi
Publikováno v:
Iranian Biomedical Journal
Background The expression of bio-therapeutic proteins in mammalian cells, such as CHO, attains high homogeneity related to post-translational modifications. Although CHO remains the most popular cell line for bestselling biotherapeutic proteins on th
Autor:
Farzaneh Barkhordari, Vahid Khalaj, Mohammadreza Kazemali, Keivan Majidzadeh-A, Ahmad Adeli, amir hossein saadatirad, Fereidoun Mahboudi, Najmeh Zarei, Soroush Sardari
Publikováno v:
Enzyme and Microbial Technology. 67:82-86
Fibrinolytic agents are widely used in treatment of the thromboembolic disorders. The new generations like recombinant tissue plasminogen activator (t-PA, alteplase) are not showing promising results in clinical practice in spite of displaying specif
Expression of a Novel Chimeric-Truncated tPA in Pichia pastoris with Improved Biochemical Properties
Autor:
Mohammadreza Kazemali, Fatemeh Davami, Farzaneh Barkhordari, Ahmad Adeli, Najmeh Zarei, Soroush Sardari, Fereidoun Mahboudi, Amirhossein Saadatirad
Publikováno v:
Molecular Biotechnology. 56:1143-1150
Thrombolytic therapy by plasminogen activators (PAs) has been a main goal in the treatment of acute myocardial infarction. Despite improved outcomes of currently available thrombolytic therapies, all these agents have different drawbacks that may res